Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HPV16' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 85 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cimoli, G; Valenti, M; Ottoboni, C; Parodi, S
      HPV16-E6 enhances mitoxantrone sensitivity in a human ovarian cancer line:an isolated instance or a trend?

      INTERNATIONAL JOURNAL OF ONCOLOGY
    2. Stoppler, H; Malerczyk, C; Block, K; Aigner, A; Czubayko, F
      The human papillomavirus (HPV) 16 E6 oncoprotein leads to an increase in gene expression of the angiogenic switch molecule FGF-BP in non-immortalizedhuman keratinocytes

      ONCOGENE
    3. Gu, JJ; Rubin, RM; Yuan, ZM
      A sequence element of p53 that determines its susceptibility to viral oncoprotein-targeted degradation

      ONCOGENE
    4. Di Lonardo, A; Marcante, ML; Poggiali, F; Hamsoikova, E; Venuti, A
      Egg yolk antibodies against the E7 oncogenic protein of human papillomavirus type 16

      ARCHIVES OF VIROLOGY
    5. Mikyskova, R; Bubenik, J; Mendoza, L; Vonka, V; Smahel, M; Simova, J; Jandlova, T
      Local cytokine treatment of HPV16-associated tumours results in inhibitionof their lung metastases

      CLINICAL & EXPERIMENTAL METASTASIS
    6. Pastrana, DV; Vass, WC; Lowy, DR; Schiller, JT
      NHPV16VLP vaccine induces human antibodies that neutralize divergent variants of HPV16

      VIROLOGY
    7. Zehbe, I; Tachezy, R; Mytilineos, J; Voglino, G; Mikyskova, I; Delius, H; Marongiu, A; Gissmann, L; Wilander, E; Tommasino, M
      Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes

      INTERNATIONAL JOURNAL OF CANCER
    8. Hildesheim, A; Schiffman, M; Bromley, C; Wacholder, S; Herrero, R; Rodriguez, AC; Bratti, MC; Sherman, ME; Scarpidis, U; Lin, QQ; Terai, M; Bromley, RL; Buetow, K; Apple, RJ; Burk, RD
      Human papillomavirus type 16 variants and risk of cervical cancer

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    9. Lehtinen, M; Kibur, M; Luostarinen, T; Anttila, A; Pukkala, E
      Prospects for phase III-IVHPV vaccination trials in the Nordic countries and in Estonia

      JOURNAL OF CLINICAL VIROLOGY
    10. Le Poole, IC; Boissy, RE; Sarangarajan, R; Chen, J; Forristal, JJ; Sheth, P; Westerhof, W; Babcock, G; Das, PK; Saelinger, CB
      PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum

      IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    11. Cornelison, TL
      Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment

      CURRENT OPINION IN ONCOLOGY
    12. Schwartz, JL; Jordan, R; Kaufmann, WK; Rasey, J; Russell, KJ
      Evidence for the expression of radiation-induced potentially lethal damagebeing a p53-dependent process

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    13. Lopez-Ocejo, O; Viloria-Petit, A; Bequet-Romero, M; Mukhopadhyay, D; Rak, J; Kerbel, RS
      Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner

      ONCOGENE
    14. Reshkin, SJ; Bellizzi, A; Caldeira, S; Albarani, V; Malanchi, I; Poignee, M; Alunni-Fabbroni, M; Casavola, V; Tommasino, M
      Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes

      FASEB JOURNAL
    15. Matsumoto, K; Yoshikawa, H; Nakagawa, S; Tang, XH; Yasugi, T; Kawana, K; Sekiya, S; Hirai, Y; Kukimoto, T; Kanda, T; Taketani, Y
      Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population

      CANCER LETTERS
    16. Szarka, K; Veress, G; Juhasz, A; Konya, J; Sapy, T; Soos, G; Hernadi, Z; Gergely, L
      Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers

      ANTICANCER RESEARCH
    17. Dahm-Daphi, J
      p53: Biology and role for cellular radiosensitivity

      STRAHLENTHERAPIE UND ONKOLOGIE
    18. Luxton, J; Mant, C; Greenwood, B; Derias, N; Nath, R; Shepherd, P; Cason, J
      HPV16 E6 oncogene variants in women with cervical intraepithelial neoplasia

      JOURNAL OF MEDICAL VIROLOGY
    19. Choo, CK; Ling, MT; Suen, CKM; Chan, KW; Kwong, YL
      Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells

      GYNECOLOGIC ONCOLOGY
    20. Carter, JJ; Koutsky, LA; Hughes, JP; Lee, SK; Kuypers, J; Kiviat, N; Galloway, DA
      Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection

      JOURNAL OF INFECTIOUS DISEASES
    21. Elson, DA; Riley, RR; Lacey, A; Thordarson, G; Talamantes, FJ; Arbeit, JM
      Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis

      CANCER RESEARCH
    22. Elson, DA; Ryan, HE; Snow, JW; Johnson, R; Arbeit, JM
      Coordinate up-regulation of hypoxia inducible factor (HIF)-1 alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing

      CANCER RESEARCH
    23. Andersson, S; Alemi, M; Rylander, E; Strand, A; Larsson, B; Sallstrom, J; Wilander, E
      Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions

      BRITISH JOURNAL OF CANCER
    24. Strieth, S; Hartschuh, W; Pilz, L; Fusenig, NE
      Angiogenic switch occurs late in squamous cell carcinomas of human skin

      BRITISH JOURNAL OF CANCER
    25. Kisseljov, FL
      Virus-associated human tumors: Cervical carcinomas and papilloma viruses

      BIOCHEMISTRY-MOSCOW
    26. Bequet-Romero, M; Lopez-Ocejo, O
      Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    27. Saranath, D; Tandle, AT; Teni, TR; Dedhia, PM; Borges, AM; Parikh, D; Sanghavi, V; Mehta, AR
      p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India

      ORAL ONCOLOGY
    28. Rupnow, BA; Knox, SJ
      The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy

      APOPTOSIS
    29. Schwartz, JL; Rasey, J; Wiens, L; Jordan, R; Russell, KJ
      Functional inactivation of p53 by HPV-E6 transformation is associated witha reduced expression of radiation-induced potentially lethal damage

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    30. Luscher-Firzlaff, JM; Westendorf, JM; Zwicker, J; Burkhardt, H; Henriksson, M; Muller, R; Pirollet, F; Luscher, B
      Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation

      ONCOGENE
    31. Fournier, N; Raj, K; Saudan, P; Utzig, S; Sahli, R; Simanis, V; Beard, P
      Expression of human papillomavirus 16 E2 protein in Schizosaccharomyces pombe delays the initiation of mitosis

      ONCOGENE
    32. Sekiguchi, T; Nishimoto, T; Hunter, T
      Overexpression of D-type cyclins, E2F-1, SV40 large T antigen and HPV16 E7rescue cell cycle arrest of tsBN462 cells caused by the CCG1/TAF(II)250 mutation

      ONCOGENE
    33. Coussens, LM; Raymond, WW; Bergers, G; Laig-Webster, M; Behrendtsen, O; Werb, Z; Caughey, GH; Hanahan, D
      Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis

      GENES & DEVELOPMENT
    34. Hilditch-Maguire, PA; Lieppe, DM; West, D; Lambert, PF; Frazer, IH
      T cell-mediated and non-specific inflammatory mechanisms contribute to theskin pathology of HPV 16 E6E7 transgenic mice

      INTERVIROLOGY
    35. Geiger, C; Weber, KJ; Wenz, F
      Radiation induced chromosome aberrations and clonogenic survival in human lymphoblastoid cell lines with different p53 status

      STRAHLENTHERAPIE UND ONKOLOGIE
    36. Zhurbitskaya, VA; Fedorova, LI; Yartseva, NM; Savel'eva, LV; Zelenin, AV; Kisseljov, FL
      Transformation of immortalized rat embryo fibroblasts with E7 gene of type16 human papilloma virus

      MOLECULAR BIOLOGY
    37. Vogt, B; Zerfass-Thome, K; Schulze, A; Botz, JW; Zwerschke, W; Jansen-Durr, P
      Regulation of cyclin E gene expression by the human papillomavirus type 16E7 oncoprotein

      JOURNAL OF GENERAL VIROLOGY
    38. Brown, JM; Wouters, BG
      Apoptosis, p53, and tumor cell sensitivity to anticancer agents

      CANCER RESEARCH
    39. Syljuasen, RG; Krolewski, B; Little, JB
      Loss of normal G(1) checkpoint control is an early step in carcinogenesis,independent p53 status

      CANCER RESEARCH
    40. Dahlberg, WK; Azzam, EI; Yu, YJ; Little, JB
      Response of human tumor cells of varying radiosensitivity and radiocurability to fractionated irradiation

      CANCER RESEARCH
    41. RONCO LV; KARPOVA AY; VIDAL M; HOWLEY PM
      HUMAN-PAPILLOMAVIRUS-16 E6 ONCOPROTEIN BINDS TO INTERFERON REGULATORYFACTOR-3 AND INHIBITS ITS TRANSCRIPTIONAL ACTIVITY

      Genes & development
    42. POREBA E; GOZDZICKAJOZEFIAK A; KEDZIA H
      STUDY ON INTERACTION OF PROTEINS ISOLATED FROM EPITHELIAL CERVICAL TISSUE WITH GLUCOCORTICOID-RESPONSE ELEMENT OF HPV16

      European journal of gynaecological oncology
    43. YAM HF; WANG ZH; OR PC; WANG SW; LI J; CHEW EC
      EFFECT OF GLUCOCORTICOID HORMONE ON NUCLEAR MATRIX IN CERVICAL-CANCERCELLS IN-VITRO

      Anticancer research
    44. PEI XF; SHERMAN L; SUN YH; SCHLEGEL R
      HPV-16 E7 PROTEIN BYPASSES KERATINOCYTE GROWTH-INHIBITION BY SERUM AND CALCIUM

      Carcinogenesis (New York. Print)
    45. SCHILLING B; DEMEDINA T; SYKEN J; VIDAL M; MUNGER K
      A NOVEL HUMAN DNAJ PROTEIN, HTID-1, A HOMOLOG OF THE DROSOPHILA TUMOR-SUPPRESSOR PROTEIN TID56, CAN INTERACT WITH THE HUMAN-PAPILLOMAVIRUS TYPE-16 E7 ONCOPROTEIN

      Virology (New York, N.Y. Print)
    46. RADY PL; SCHNADIG VJ; WEISS RL; HUGHES TK; TYRING SK
      MALIGNANT TRANSFORMATION OF RECURRENT RESPIRATORY PAPILLOMATOSIS ASSOCIATED WITH INTEGRATED HUMAN-PAPILLOMAVIRUS TYPE-11 DNA AND MUTATION OF P53

      The Laryngoscope
    47. MARTIN LG; DEMERS GW; GALLOWAY DA
      DISRUPTION OF THE G(1) S TRANSITION IN HUMAN-PAPILLOMAVIRUS TYPE-16 E7-EXPRESSING HUMAN-CELLS IS ASSOCIATED WITH ALTERED REGULATION OF CYCLIN-E/

      Journal of virology
    48. XI LF; CRITCHLOW CW; WHEELER CM; KOUTSKY LA; GALLOWAY DA; KUYPERS J; HUGHES JP; HAWES SE; SURAWICZ C; GOLDBAUM G; HOLMES KK; KIVIAT NB
      RISK OF ANAL CARCINOMA IN-SITU IN RELATION TO HUMAN-PAPILLOMAVIRUS TYPE-16 VARIANTS

      Cancer research
    49. MOTA FF; RAYMENT NB; KANAN JH; SINGER A; CHAIN BM
      DIFFERENTIAL REGULATION OF HLA-DQ EXPRESSION BY KERATINOCYTES AND LANGERHANS CELLS IN NORMAL AND PREMALIGNANT CERVICAL EPITHELIUM

      Tissue antigens
    50. LITTLE JB; LI CY; NAGASAWA H; HUANG H
      INFLUENCE OF P53 EXPRESSION ON RADIOSENSI TIVITY OF HUMAN NORMAL AND TUMOR-CELLS

      Journal de chimie physique et de physico-chimie biologique
    51. YAM HF; CHEN HB; YANG L; WANG SW; CHENGCHEW SB; WANG ZH; CHEW EC
      HUMAN PAPILLOMAVIRUS-16 E6 AND E7 ARE ASSOCIATED WITH THE NUCLEAR MATRIX OF CERVICAL-CARCINOMA CELLS

      Oncology Reports
    52. SAVELIEVA E; BELAIR CD; NEWTON MA; DEVRIES S; GRAY JW; WALDMAN F; REZNIKOFF CA
      20Q GAIN ASSOCIATES WITH IMMORTALIZATION - 20Q13.2 AMPLIFICATION CORRELATES WITH GENOME INSTABILITY IN HUMAN PAPILLOMAVIRUS 16 E7 TRANSFORMED HUMAN UROEPITHELIAL CELLS

      Oncogene
    53. YU YJ; LI CY; LITTLE JB
      ABROGATION OF P53 FUNCTION BY HPV16 E6 GENE DELAYS APOPTOSIS AND ENHANCES MUTAGENESIS BUT DOES NOT ALTER RADIOSENSITIVITY IN TK6 HUMAN LYMPHOBLAST CELLS

      Oncogene
    54. OHTA Y; TSUTSUMI K; KIKUCHI K; YASUMOTO S
      2 DISTINCT HUMAN UTERINE CERVICAL EPITHELIAL-CELL LINES ESTABLISHED AFTER TRANSFECTION WITH HUMAN-PAPILLOMAVIRUS-16 DNA

      Japanese journal of cancer research
    55. BERNER A; FRANZEN S; HOLM R
      HPV-16 INFECTION IN A PATIENT WITH 2 PRIMARY SQUAMOUS-CELL CARCINOMAS- OF THE UTERINE CERVIX AND THE ANAL MUCOSA

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    56. YANG L; YAM HF; CHENGCHEW SB; WONG SW; LOOG EPL; CHEW EC
      THE ASSOCIATION OF HPV-16 DNA WITH SPECIFIC NUCLEAR MATRIX PROTEINS OF NORMAL AND CERVICAL-CARCINOMA CELL

      Anticancer research
    57. HALL WS; GOTOMANDEVILLE R; SHIH HA; SHANK PR; BRAUN L
      MOLECULAR ANALYSIS OF EPISOMAL HUMAN-PAPILLOMAVIRUS TYPE-16 DNA IN A CERVICAL-CARCINOMA CELL-LINE

      Virus research
    58. PHILLIPS AC; VOUSDEN KH
      ANALYSIS OF THE INTERACTION BETWEEN HUMAN PAPILLOMAVIRUS TYPE-16 E7 AND THE TATA-BINDING PROTEIN, TBP

      Journal of General Virology
    59. HUANG YZ; KONG YY; WANG Y; QI GR; LU CD
      IDENTIFICATION OF ACTIVITY OF ANTI-HPV16 E7-RIBOZYME EXPRESSED IN CV-1 CELLS

      Chinese Science Bulletin
    60. SHARMA BK; RAY A; MURTHY NS
      PREVALENCE OF SERUM ANTIBODIES TO SYNTHETIC PEPTIDES TO HPV16 EPITOPES AMONG INDIAN WOMEN WITH CERVICAL NEOPLASIA

      European journal of cancer
    61. PUTHENVEETTIL JA; FREDERICKSON SM; REZNIKOFF CA
      APOPTOSIS IN HUMAN PAPILLOMAVIRUS16 E7-IMMORTALIZED, BUT NOT E6-IMMORTALIZED HUMAN UROEPITHELIAL CELLS

      Oncogene
    62. WANG YS; OKAN I; POKROVSKAJA K; WIMAN KG
      ABROGATION OF P53-INDUCED G1 ARREST BY THE HPV-16-E7 PROTEIN DOES NOTINHIBIT P53-INDUCED APOPTOSIS

      Oncogene
    63. BAGOT M; CHARUE D; CERNI C; REVUZ J; MENEGUZZI G
      INDUCTION OF RAT CD4(-CELL LINES SPECIFIC FOR HUMAN PAPILLOMAVIRUS TYPE-16 ANTIGENS() PROLIFERATIVE AND MOUSE CD8(+) CYTOTOXIC T)

      Research in virology
    64. KIKUCHI K; TANIGUCHI A; YASUMOTO S
      INDUCTION OF THE HPV16 ENHANCER ACTIVITY BY JUN-B AND C-FOS THROUGH COOPERATION OF THE PROMOTER-PROXIMAL AP-1 SITE AND THE EPITHELIAL-CELL TYPE-SPECIFIC REGULATORY ELEMENT IN FIBROBLASTS

      Virus genes
    65. PFISTER H
      THE ROLE OF HUMAN PAPILLOMAVIRUS IN ANOGENITAL CANCER

      Obstetrics and gynecology clinics of North America
    66. KHARE S; KUMAR KU; TANG SC; PATER MM; PATER A
      UP-REGULATION OF HORMONE RESPONSE OF HUMAN PAPILLOMAVIRUS TYPE-16 EXPRESSION AND INCREASED DNA-PROTEIN BINDING BY CONSENSUS MUTATIONS OF VIRAL GLUCOCORTICOID RESPONSE ELEMENTS

      Journal of medical virology
    67. WONG HK; ZIFF EB
      THE HUMAN PAPILLOMAVIRUS TYPE-16 E7 PROTEIN COMPLEMENTS ADENOVIRUS TYPE 5 E1A AMINO-TERMINUS-DEPENDENT TRANSACTIVATION OF ADENOVIRUS TYPE-5EARLY GENES AND INCREASES ATF AND OCT-1 DNA-BINDING ACTIVITY

      Journal of virology
    68. SUZUKI T; TSUTSUMI K; NAKAJIMA T; HARA F; KIKUCHI K; YASUMOTO S
      SPONTANEOUS MUTATION OF P53 GENE IN HUMAN PAPILLOMAVIRUS TYPE-16 E7-IMMORTALIZED HUMAN LARYNGEAL EPITHELIAL-CELLS

      Acta oto-laryngologica
    69. VOUSDEN KH
      REGULATION OF THE CELL-CYCLE BY VIRAL ONCOPROTEINS

      Seminars in cancer biology
    70. YAM YF; CHEW EC; YANG L; CHENGCHEW SB; DING MX
      HUMAN PAPILLOMAVIRUS TYPE-16 DNA INTEGRATION IN NUCLEAR MATRIX AND CHROMOSOME SCAFFOLD ASSOCIATED DNA IN A CERVICAL-CARCINOMA CELL-LINE

      Oncology Reports
    71. LABEIT D; FRIESE K
      SEQUENCE-ANALYSIS OF PCR-AMPLIFICATIONS I N FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUES

      Gynakologisch-geburtshilfliche Rundschau
    72. MAZZARELLI JM; ATKINS GB; GEISBERG JV; RICCIARDI RP
      THE VIRAL ONCOPROTEINS AD5 E1A, HPV16 E7 AND SV40 TAG BIND A COMMON REGION OF THE TBP-ASSOCIATED FACTOR-110

      Oncogene
    73. CERNI C; BOUSSET K; SEELOS C; BURKHARDT H; HENRIKSSON M; LUSCHER B
      DIFFERENTIAL-EFFECTS BY MAD AND MAX ON TRANSFORMATION BY CELLULAR ANDVIRAL ONCOPROTEINS

      Oncogene
    74. KONDOH G; HAYASAKA N; LI Q; NISHIMUNE Y; HAKURA A
      AN IN-VIVO MODEL FOR RECEPTOR TYROSINE KINASE AUTOCRINE PARACRINE ACTIVATION - AUTO-STIMULATED KIT RECEPTOR ACTS AS A TUMOR-PROMOTING FACTOR IN PAPILLOMAVIRUS-INDUCED TUMORIGENESIS/

      Oncogene
    75. YAMADA T; YAMASHITA T; NISHIKAWA T; FUJIMOTO S; FUJINAGA K
      BIOLOGIC ACTIVITY OF HUMAN PAPILLOMAVIRUS TYPE-16 E6 E7 CDNA CLONES ISOLATED FROM SIHA CERVICAL-CARCINOMA CELL-LINE/

      Virus genes
    76. CHENG S; SCHMIDTGRIMMINGER DC; MURANT T; BROKER TR; CHOW LT
      DIFFERENTIATION-DEPENDENT UP-REGULATION OF THE HUMAN PAPILLOMAVIRUS E7 GENE REACTIVATES CELLULAR DNA-REPLICATION IN SUPRABASAL DIFFERENTIATED KERATINOCYTES

      Genes & development
    77. SHIRASAWA H; KINOSHITA T; SHINO Y; MORI K; SHIMIZU K; SIMIZU B
      CLONING AND SEQUENCING OF THE MURINE FARNESYLTRANSFERASE ALPHA-ENCODING CDNA FROM A CELL-LINE WHICH EXPRESSES THE HUMAN PAPILLOMAVIRUS TYPE-16 E6 GENE

      Gene
    78. HIBMA MH; RAJ K; ELY SJ; STANLEY M; CRAWFORD L
      THE INTERACTION BETWEEN HUMAN PAPILLOMAVIRUS TYPE-16 E1 AND E2 PROTEINS IS BLOCKED BY AN ANTIBODY TO THE N-TERMINAL REGION OF E2

      European journal of biochemistry
    79. TINDLE RW; CROFT S; HERD K; MALCOLM K; GECZY AF; STEWART T; FERNANDO GJP
      A VACCINE CONJUGATE OF ISCAR IMMUNOCARRIER AND PEPTIDE EPITOPES OF THE E7 CERVICAL CANCER-ASSOCIATED PROTEIN OF HUMAN PAPILLOMAVIRUS TYPE-16 ELICITS SPECIFIC TH1-TYPE AND TH2-TYPE RESPONSES IN IMMUNIZED MICE IN THE ABSENCE OF OIL-BASED ADJUVANTS

      Clinical and experimental immunology
    80. REZNIKOFF CA; BELAIR C; SAVELIEVA E; ZHAI Y; PFEIFER K; YEAGER T; THOMPSON KJ; DEVRIES S; BINDLEY C; NEWTON MA; SEKHON G; WALDMAN F
      LONG-TERM GENOME STABILITY AND MINIMAL GENOTYPIC AND PHENOTYPIC ALTERATIONS IN HPV16 E7-, BUT NOT E6-, IMMORTALIZED HUMAN UROEPITHELIAL CELLS

      Genes & development
    81. MAY M; DONG XP; BEYERFINKLER E; STUBENRAUCH F; FUCHS PG; PFISTER H
      THE E6 E7 PROMOTER OF EXTRACHROMOSOMAL HPV16 DNA IN CERVICAL CANCERS ESCAPES FROM CELLULAR REPRESSION BY MUTATION OF TARGET SEQUENCES FOR YY1/

      EMBO journal
    82. BENAMOUZIG R; JULLIAN E
      ROLE OF HUMAN PAPILLOMAVIRUS IN ESOPHAGEA L CARCINOGENESIS

      Annales de pathologie
    83. HAUSEN HZ
      DISRUPTED DICHOTOMOUS INTRACELLULAR CONTROL OF HUMAN PAPILLOMAVIRUS INFECTION IN CANCER OF THE CERVIX

      Lancet
    84. PEI XF; WU M
      CLONAL GROWTH AND ORIGIN OF 2 HUMAN KERATINOCYTE CELL-LINES TRANSFORMED BY HUMAN PAPILLOMAVIRUS TYPE 16 DNA

      Cancer letters
    85. HUANG ES; GUTSCH D; TZUNG KW; LIN CT
      DETECTION OF LOW-LEVEL OF HUMAN PAPILLOMA-VIRUS TYPE-16 DNA-SEQUENCESIN CANCER CELL-LINES DERIVED FROM 2 WELL-DIFFERENTIATED NASOPHARYNGEAL CANCERS

      Journal of medical virology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 02:19:36